Below are the most recent publications written about "Eye Enucleation" by people in Profiles.
-
Kaliki S, Vempuluru VS, Bakal KR, Dorji S, Tanna V, Shields CN, Fallon SJ, Raval V, Ahmad A, Mushtaq A, Hussain M, Yousef YA, Mohammad M, Roy SR, Huque F, Tatiana U, Yuri S, Vladimir P, Zambrano SC, Alarc?n-Le?n S, Valdiviezo-Zapata C, Vargas-Martorellet M, Gutierrez-Chira C, Buitrago M, Ortiz JS, Diaz-Coronado R, Tripathy D, Rath S, Patil G, Berry JL, Pike S, Brown B, Tanabe M, Frenkel S, Eiger-Moscovich M, Pe'er J, Shields CL, Eagle RC, Laiton A, Velasco AM, Vega K, DeSimone J, Bejjanki KM, Kapoor AG, Venkataraman A, Bryant V, Reddy MA, Sagoo MS, Hubbard GB, Azarcon CP, Olson TA, Grossniklaus H, Rolfe O, Staffieri SE, O'Day R, Mathew AA, Elder JE, McKenzie JD, Fabian ID, Shemesh R, Vishnevskia-Dai V, Ali MH, Jakati S, Mishra DK, Palkonda VAR. HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATION: A Global Study Of 1,426 Patients From 5 Continents. Retina. 2024 12 01; 44(12):2105-2115.
-
Arazi M, Baum A, Casavilca-Zambrano S, Alarcon-Leon S, Diaz-Coronado R, Ahmad A, Mushtaq A, Hussain M, Ushakova T, Yuri S, Vladimir P, Shields CL, Eagle RC, Berry JL, Pike S, Brown B, Roy SR, Huque F, Fabian I, Frenkel S, Eiger-Moscovich M, Pe'er J, Hubbard GB, Olson TA, Grossniklaus H, Reddy MA, Sagoo MS, Staffieri SE, Elder JE, McKenzie JD, Tanabe M, Kaliki S, Fabian ID. Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma. Am J Ophthalmol. 2024 Dec; 268:399-408.
-
Adams OE, Tanke LB, Mundae R, Sodhi GS, Yu MD, Yonekawa Y, Dalvin LA, Tang PH. Trends in the Clinical Presentation of Uveal Melanoma During the COVID-19 Pandemic. Ophthalmic Surg Lasers Imaging Retina. 2024 May; 55(5):278-284.
-
Eiger-Moscovich M, Shields CL, Eagle RC, Milman T. BRCA-associated protein1 (BAP1) immunohistochemical stain reliability in postbrachytherapy uveal melanoma enucleation specimens. Indian J Ophthalmol. 2024 May 01; 72(Suppl 3):S459-S467.
-
Dockery PW, DeSimone JD, Liu CK, Achuck K, Hamburger J, Bas Z, Shields CL. Effectiveness of treatment for iris melanoma: surgical versus radiotherapeutic approaches. Can J Ophthalmol. 2024 Oct; 59(5):329-334.
-
Zhang MM, Radulovich NP, Fu R, Eagle RC, Stefanyszyn MA. Electrical burn of the eye and orbit with severe delayed sequelae from an arc welding accident. Orbit. 2024 Oct; 43(5):596-599.
-
Kaliki S, Shields CL, Cassoux N, Munier FL, Chantada G, Grossniklaus HE, Yoshikawa H, Fabian ID, Berry JL, McKenzie JD, Kimani K, Reddy MA, Parulekar M, Tanabe M, Furuta M, Grigorovski N, Chevez-Barrios P, Scanlan P, Eagle RC, Rashid R, Coronado RD, Sultana S, Staffieri S, Frenkel S, Suzuki S, Ushakova TL, Ji X. Defining High-risk Retinoblastoma: A Multicenter Global Survey. JAMA Ophthalmol. 2022 Jan 01; 140(1):30-36.
-
Bas Z, Dalvin LA, Tadepalli S, Rao R, Shah A, Leahey AM, Shields CL. Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients. Asia Pac J Ophthalmol (Phila). 2021 Jan 19; 10(4):373-380.
-
Xu TT, Pulido JS, Deufel CL, Corbin KS, Petersen IA, Dalvin LA. Clinical outcomes of Modified Collaborative Ocular Melanoma Study IRIS plaques for treatment of iris, iridociliary, and ciliary body melanoma. Eye (Lond). 2021 10; 35(10):2754-2762.
-
Williams BK, Di Nicola M, Acaba-Berrocal LA, Milman T, Mashayekhi A, Lucio-Alvarez JA, Eagle RC, Shields JA, Shields CL. Adenoma and Adenocarcinoma of the Retinal Pigment Epithelium: A Review of 51 Consecutive Patients. Ophthalmol Retina. 2020 08; 4(8):829-839.